Literature DB >> 21087743

Neurological complications of systemic cancer.

Mustafa Khasraw1, Jerome B Posner2.   

Abstract

Neurological complications of systemic cancer-those arising outside the nervous system-can be distressing, disabling, and sometimes fatal. Diagnosis is often difficult because different neurological disorders may present with similar signs and symptoms. Furthermore, comorbid neurological illnesses, common in elderly patients with cancer, can complicate diagnosis. Early diagnosis and aggressive treatment can improve neurological symptoms and can substantially enhance a patient's quality of life. We approach the problem of neurological complications of systemic cancer as would a neurologist: first by identifying the anatomical area or areas that are affected (ie, brain, spinal cord, peripheral nerve), then by evaluating the diagnostic approach, considering the symptoms and signs and including appropriate laboratory tests, and finally, by recommending treatment. We focus on disorders that are difficult to diagnose, need neurological consultation, and for which effective treatments exist.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21087743     DOI: 10.1016/S1474-4422(10)70220-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  17 in total

Review 1.  Salting the Soil: Targeting the Microenvironment of Brain Metastases.

Authors:  Ethan S Srinivasan; Aaron C Tan; Carey K Anders; Ann Marie Pendergast; Dorothy A Sipkins; David M Ashley; Peter E Fecci; Mustafa Khasraw
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.261

Review 2.  Management of Brain Metastases in the New Era of Checkpoint Inhibition.

Authors:  Adam Lauko; Bicky Thapa; Vyshak Alva Venur; Manmeet S Ahluwalia
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-18       Impact factor: 5.081

Review 3.  Immune Checkpoint Inhibitors for Brain Metastases.

Authors:  Aaron C Tan; Amy B Heimberger; Alexander M Menzies; Nick Pavlakis; Mustafa Khasraw
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

Review 4.  Towards updated understanding of brain metastasis.

Authors:  Shuncong Wang; Yuanbo Feng; Lei Chen; Jie Yu; Chantal Van Ongeval; Guy Bormans; Yue Li; Yicheng Ni
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 5.  Expected Paradigm Shift in Brain Metastases Therapy-Immune Checkpoint Inhibitors.

Authors:  Vishal Jindal; Sorab Gupta
Journal:  Mol Neurobiol       Date:  2018-01-30       Impact factor: 5.590

Review 6.  Emerging pharmacotherapy for cancer patients with cognitive dysfunction.

Authors:  Justin Davis; Fiona M Ahlberg; Michael Berk; David M Ashley; Mustafa Khasraw
Journal:  BMC Neurol       Date:  2013-10-24       Impact factor: 2.474

7.  Neurological complications of breast cancer: study protocol of a prospective cohort study.

Authors:  Susana Pereira; Filipa Fontes; Teresa Sonin; Teresa Dias; Maria Fragoso; José Castro-Lopes; Nuno Lunet
Journal:  BMJ Open       Date:  2014-10-28       Impact factor: 2.692

8.  Characteristics of cryptogenic stroke in cancer patients.

Authors:  Yasufumi Gon; Shuhei Okazaki; Yasukazu Terasaki; Tsutomu Sasaki; Toshiki Yoshimine; Manabu Sakaguchi; Hideki Mochizuki
Journal:  Ann Clin Transl Neurol       Date:  2016-02-11       Impact factor: 4.511

Review 9.  Using lithium as a neuroprotective agent in patients with cancer.

Authors:  Mustafa Khasraw; David Ashley; Greg Wheeler; Michael Berk
Journal:  BMC Med       Date:  2012-11-02       Impact factor: 8.775

10.  Role of the nervous system in cancer metastasis.

Authors:  Sha Li; Yanlai Sun; Dongwei Gao
Journal:  Oncol Lett       Date:  2013-01-31       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.